{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:49:12Z","timestamp":1788461352160,"version":"build-2803163510"},"reference-count":46,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CLEP"],"DOI":"10.2147\/clep.s514738","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:00:12Z","timestamp":1757998812000},"page":"765-778","source":"Crossref","is-referenced-by-count":3,"title":["Post-Marketing Safety Concerns with Efgartigimod alfa: A Pharmacovigilance Analysis Based on the Food and Drug Administration Adverse Event Reporting System Database"],"prefix":"10.2147","volume":"Volume 17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4731-8410","authenticated-orcid":true,"given":"Jinlong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1212\/WNL.98.18_supplement.952","volume":"98","author":"Ruzhansky","year":"2022","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.3390\/jcm11061597","volume":"11","author":"Alhaidar","year":"2022","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s40265-022-01726-y","volume":"82","author":"Menon","year":"2022","journal-title":"Drugs"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/j.jocn.2014.03.019","volume":"21","author":"Nagappa","year":"2014","journal-title":"J Clin Neurosci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1756286419832242","DOI":"10.1177\/1756286419832242","volume":"12","author":"Schneider-Gold","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s13311-022-01181-3","volume":"19","author":"Vanoli","year":"2022","journal-title":"Neurotherapeutics"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1186\/s12967-024-05751-1","volume":"22","author":"Gu","year":"2024","journal-title":"J Transl Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s40265-022-01678-3","volume":"82","author":"Heo","year":"2022","journal-title":"Drugs"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1002\/acn3.52142","volume":"11","author":"Luo","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1007\/s10072-024-07460-5","volume":"45","author":"Yang","year":"2024","journal-title":"Neurol Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1007\/s00415-023-11699-x","volume":"270","author":"Meisel","year":"2023","journal-title":"J Neurol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1007\/s00415-022-11517-w","volume":"270","author":"Sacca","year":"2023","journal-title":"J Neurol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"6209","DOI":"10.1007\/s00415-024-12588-7","volume":"271","author":"Pane","year":"2024","journal-title":"J Neurol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/00001813-200211002-00002","volume":"13","author":"Cerny","year":"2002","journal-title":"Anticancer Drugs"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1478-3231.2010.02396.x","volume":"31","author":"Roche","year":"2011","journal-title":"Liver Int"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e610","DOI":"10.1212\/WNL.0000000000011207","volume":"96","author":"Mantegazza","year":"2021","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","volume":"96","author":"Narayanaswami","year":"2021","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/amiajnl-2013-001612","volume":"21","author":"Iyer","year":"2014","journal-title":"J Am Med Inform Assoc"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2147\/CLEP.S365513","volume":"14","author":"Shu","year":"2022","journal-title":"Clin Epidemiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2165\/00002018-200427080-00010","volume":"27","author":"Brown","year":"2004","journal-title":"Drug Saf"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/pds.668","volume":"11","author":"van Puijenbroek","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","volume":"25","author":"Szarfman","year":"2002","journal-title":"Drug Saf"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002280050466","volume":"54","author":"Bate","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/pds.1058","volume":"14","author":"Moore","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s002280000215","volume":"56","author":"van Puijenbroek","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1369384","DOI":"10.3389\/fphar.2024.1369384","volume":"15","author":"Chen","year":"2024","journal-title":"Front Pharmacol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jad.2023.11.025","volume":"346","author":"Jiang","year":"2024","journal-title":"J Affect Disord"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1389814","DOI":"10.3389\/fphar.2024.1389814","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Pharmacol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/jcpt.13024","volume":"45","author":"Kinoshita","year":"2020","journal-title":"J Clin Pharm Ther"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2288-14-17","volume":"14","author":"Leroy","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s40263-023-01000-z","volume":"37","author":"Heo","year":"2023","journal-title":"CNS Drugs"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e2661","DOI":"10.1212\/WNL.0000000000007600","volume":"92","author":"Howard","year":"2019","journal-title":"Neurology"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1111\/ene.15872","volume":"30","author":"Sacca","year":"2023","journal-title":"Eur J Neurol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s40263-024-01062-7","volume":"38","author":"Ma","year":"2024","journal-title":"CNS Drugs"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2217\/imt-2022-0298","volume":"15","author":"Sivadasan","year":"2023","journal-title":"Immunotherapy"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/mus.28003","volume":"69","author":"Singer","year":"2024","journal-title":"Muscle Nerve"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1080\/1744666X.2022.2106972","volume":"18","author":"Dos Santos","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mehy.2018.06.002","volume":"118","author":"Bauza","year":"2018","journal-title":"Med Hypotheses"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"150","DOI":"10.18565\/urology.2017.5.150-154","volume":"5_2017","author":"Khamidullin","year":"2017","journal-title":"Urologiia"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3389\/fimmu.2014.00408","volume":"5","author":"Baker","year":"2014","journal-title":"Front Immunol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1080\/14712598.2021.1948529","volume":"21","author":"Mazhar","year":"2021","journal-title":"Expert Opin Biol Ther"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1007\/s10072-024-07368-0","volume":"45","author":"Di Stefano","year":"2024","journal-title":"Neurol Sci"}],"container-title":["Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/107004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/107004","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:00:13Z","timestamp":1757998813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/post-marketing-safety-concerns-with-efgartigimod-alfa-a-pharmacovigila-peer-reviewed-fulltext-article-CLEP"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":46,"URL":"https:\/\/doi.org\/10.2147\/clep.s514738","relation":{},"ISSN":["1179-1349"],"issn-type":[{"value":"1179-1349","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}